News | Stroke | October 18, 2019

New Algorithm Expands Neurologists' Ability to Assess for Clot-removing Procedure

Researchers use artificial intelligence CT angiograms, a more readily available test, to analyze portions of the brain affected by ischemic stroke

New Algorithm Expands Neurologists' Ability to Assess for Clot-removing Procedure

October 18, 2019 — An algorithm developed by faculty at The University of Texas Health Science Center at Houston (UTHealth) can help physicians outside of major stroke treatment centers assess whether a patient suffering from ischemic stroke would benefit from an endovascular procedure to remove a clot blocking an artery.

Results of their clinical study using the algorithm were published online in the journal Stroke.[1]

Endovascular thrombectomy is a procedure that involves threading a catheter through the femoral artery in the leg all the way to the brain, where the clot can be removed mechanically. Since 2015, studies have shown it can improve outcomes for stroke patients, but only if the amount of brain tissue that has been injured is minimal at the time of treatment.

Unfortunately, advanced neuroimaging to detect within hours whether a patient is a candidate for the treatment is limited to emergent magnetic resonance imaging (MRI) or computed tomography (CT) perfusion. That kind of technology and expertise are not available at most community hospitals and primary stroke centers.

“With endovascular thrombectomy, we now have a treatment for ischemic stroke that is really revolutionary. It allows us to take stroke patients from severe disability and return them to an almost normal life,” said Sunil A. Sheth, M.D., corresponding author and assistant professor of neurology with McGovern Medical School at UTHealth. “Unfortunately, the advanced imaging techniques used currently to identify which patients benefit from this procedure are not widely available outside of large referral hospitals. As a result, most stroke patients don’t have access to guideline-based screening for these treatments.”

In response, Sheth and Luca Giancardo, Ph.D., senior author and assistant professor at UTHealth School of Biomedical Informatics, developed a machine learning tool that could be used with a widely available imaging technique, CT angiogram. The tool can analyze images by automatically “learning” subtle image patterns that can be used as a proxy for other more advanced, but not readily available, imaging modalities such as CT perfusion. The machine learning architecture, called DeepSymNet, was developed at UTHealth.

To test the tool, the research team identified patients in their stroke registry who had suffered a stroke or had conditions that mimicked stroke.

Of the 224 who had stroke, 179 had cerebral blood vessels that were blocked. The DeepSymNet algorithm learned to identify these blockages from the CT angiogram images, and trained the software to use those same images to define the area of brain that had died, using concurrent acquired CT perfusion scans as the “gold standard.”

“The advantage is you don’t have to be at an academic health center or a tertiary care hospital to determine whether this treatment would benefit the patient. And best of all, CT angiogram is already widely used for patients with stroke,” Sheth said.

For more information: www.ahajournals.org/journal/stroke

Reference

1. Sheth S.A., Lopez-Rivera V., Barman A., et al. Machine Learning–Enabled Automated Determination of Acute Ischemic Core From Computed Tomography Angiography. Stroke, published online Sept. 24, 2019. https://doi.org/10.1161/STROKEAHA.119.026189


Related Content

News | Stroke

March 10, 2026 — Medtronic has entered into a definitive agreement to acquire Scientia Vascular, a company with critical ...

Home March 12, 2026
Home
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Home March 11, 2026
Home
News | Stroke

Feb. 6, 2026 — Rapid Medical, a developer of active endovascular devices, has announced the latest results from the ...

Home February 10, 2026
Home
News | Stroke

Feb. 2, 2026 — Brainomix, a provider of AI-powered imaging tools in stroke and lung fibrosis, is introducing its new ...

Home February 02, 2026
Home
News | Stroke

Jan. 13, 2026 — A streamlined, nurse-led response for hospitalized patients experiencing an acute stroke at a Texas ...

Home January 15, 2026
Home
News | Stroke

Dec. 3, 2025 — Recross Cardio Inc., a structural heart company developing next-generation membrane sealing technology ...

Home December 04, 2025
Home
News | Stroke

Dec. 2, 2025 — Brainomix, a provider of AI-powered imaging tools in stroke and lung fibrosis, has announced the ...

Home December 03, 2025
Home
News | Stroke

Nov. 10, 2025 — Sentante, a med-tech robotics company, has successfully demonstrated a first-of-a-kind remote stroke ...

Home November 10, 2025
Home
News | Stroke

Oct. 22, 2025 — Basking Biosciences, a clinical-stage biopharmaceutical company developing the first reversible ...

Home October 22, 2025
Home
News | Stroke

Oct. 21, 2025 — At the seventeenth edition of the World Stroke Congress in Barcelona, Siemens Healthineers will present ...

Home October 21, 2025
Home
Subscribe Now